Susan Sloan

Treatment with Monoclonal Antibodies against <i>Clostridium difficile</i> Toxins

Israel Lowy, Deborah C. Molrine, Brett Leav et al. · New England Journal of Medicine · 2010 · 745 citations · Full text

Life Sciences, Infectious Diseases, Pharmacology +12

Identification and Characterization of Broadly Neutralizing Human Monoclonal Antibodies Directed against the E2 Envelope Glycoprotein of Hepatitis C Virus

Teresa J. Broering, Kerry A. Garrity, Naomi K. Boatright et al. · Journal of Virology · 2009 · 183 citations · Full text

Pharmacy, Immunology, Infectious Diseases +16

Identification and characterization of a human monoclonal antibody that potently neutralizes a broad panel of rabies virus isolates

Susan Sloan, Cathleen A. Hanlon, William C. Weldon et al. · Vaccine · 2006 · 101 citations

Pharmacy, Immunology, Infectious Diseases +14

A Proliferation Inducing Ligand (APRIL) targeted antibody is a safe and effective treatment of murine IgA nephropathy

James R. Myette, Toshiki Kano, Hitoshi Suzuki et al. · Kidney International · 2019 · 90 citations

Life Sciences, Immunology, Nephrology +12

Safety and efficacy of monoclonal antibody VIS410 in adults with uncomplicated influenza A infection: Results from a randomized, double-blind, phase-2, placebo-controlled study

Ellie Hershberger, Susan Sloan, Kristin Narayan et al. · EBioMedicine · 2019 · 87 citations · Full text

Pharmacy, Immunology, Infectious Diseases +12